Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Head & Neck|May 23, 2024
Outcomes for potentially Resectable patients undergoing primary chemoradiation treatment for T1-T2 HPV Negative oropharyngeal squamous cell carcinomaFrancisco Laxague, Naif Fnais, Hee Young Son, et al.
Surgical Oncology|September 12, 2025
Oncological and functional outcomes of salvage surgery for local oropharyngeal cancer recurrence after primary Radiation±ChemotherapyFrancisco Laxague, Naif Fnais, Dorsa Zabihi, et al.
The Laryngoscope|July 26, 2022
Risk Factors for Poor Survival Outcomes in Parotid Metastatic Cutaneous Squamous Cell CarcinomaFrancisco Laxague, Agnieszka Dzioba, Dhruv Jasani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2009
Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinomaWilliam A Michaud, Anthony C Nichols, Edmund A Mroz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2010
Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancerAnthony C Nichols, Dianne M Finkelstein, William C Faquin, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 22, 2013
High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancerAnthony C Nichols, David A Palma, Winsion Chow, et al.
Head & Neck|December 15, 2023
A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomasFrancisco Laxague, Peter Y F Zeng, Dorsa Zabihi, et al.
International Journal of Cancer|November 24, 2018
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growthKara M Ruicci, Jalna Meens, Ren X Sun, et al.
Molecular Oncology|August 9, 2019
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibitionKara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2026
What is the Impact of Treatment De-Escalation on Patient Reported Outcomes in Patients with T1-T2 Oropharyngeal Cancers? A Secondary Analysis of the ORATOR StudiesAlexa Dang, David A Palma, Anthony C Nichols, et al.
Pageof 14